The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus (Q46833522)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 December 2013

Language	Label	Description	Also known as
English	The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus	scientific article published on 27 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/24370923

The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/24370923

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

Giuseppe Daniele

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Francesco Andreozzi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Massimo Federici

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

R Guardado Mendoza

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

D Winnier

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

T V Fiorentino

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Z Pengou

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

J Cornell

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

C Jenkinson

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

E Cersosimo

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

D Tripathy

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

27 December 2013

1 reference

Europe PubMed Central

25 December 2017

http://europepmc.org/abstract/MED/24370923

Acta Diabetologica

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

51

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

123-131

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

https://scigraph.springernature.com/pub.10.1007/s00592-013-0543-1

0 references

Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Circulating leptin correlates with left ventricular mass in morbid (grade III) obesity before and after weight loss induced by bariatric surgery: a potential role for leptin in mediating human left ventricular hypertrophy

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

A unique role of monocyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Osteopontin: a novel inflammatory mediator of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Fractalkine: a cellular link between adipose tissue inflammation and vascular pathologies

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Increased number of islet-associated macrophages in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Inflammatory markers and the risk of coronary heart disease in men and women

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Increased skeletal muscle tumor necrosis factor-alpha and impaired insulin signaling persist in obese women with gestational diabetes mellitus 1 year postpartum

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Lack of association of apoE ε4 allele with insulin resistance.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Validation of a novel index to assess insulin resistance of adipose tissue lipolytic activity in obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0543-1

21 January 2018

Identifiers

10.1007/S00592-013-0543-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24370923%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46833522&oldid=2134008964"